内部人交易记录
董事尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Lalande Kevin M., 董事. Insider active across 3 companies, notably LUMOS PHARMA, INC.. Aggregated, 11 disclosures have been published. Breakdown: 8 buys · 0 sell. Total volume traded: €1m. Activity tracked since 20 May 2021. The latest transaction was disclosed on 2 April 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Lalande Kevin M.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
1,076 股Common StockSEC:0001126234-24-000115:0
175,000 股@ US$2.3581.4% 占其流量Common StockSEC:0001415889-24-010303:0
100,000 股@ US$0.91100.0% 占其流量Common StockSEC:0001209191-22-038477:0
10,000 股@ US$11.211610.1% 占其流量Common StockSEC:0001126234-21-000141:0
6,300 股@ US$11.22846.3% 占其流量Common StockSEC:0001126234-21-000138:0
8,625 股@ US$10.52038.2% 占其流量Common StockSEC:0001126234-21-000133:0
14,900 股@ US$9.87113.3% 占其流量Common StockSEC:0001126234-21-000129:0
35,679 股@ US$8.734528.4% 占其流量Common StockSEC:0001126234-21-000123:0
16,000 股@ US$8.465412.3% 占其流量Common StockSEC:0001126234-21-000117:0
31,000 股@ US$7.546221.2% 占其流量Common StockSEC:0001126234-21-000115:0
367 股0Common StockSEC:0001126234-21-000080:0
About Lalande Kevin M.
Kevin M. Lalande is an insider at Lumos Pharma, Inc.